Cash & equivalents increased 28.8%
Cash & equivalents changed +28.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +28.8% from the comparable as-filed period.
Stock-based compensation changed +57.2% from the comparable as-filed period.
Working capital / assets changed +304 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -8.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +233 basis points from the comparable as-filed period.
Free-cash-flow margin changed -1612 basis points from the comparable as-filed period.
Operating cash flow / net income changed +44.2% from the comparable as-filed period.
R&D / revenue changed +838 basis points from the comparable as-filed period.
Net income changed -13.6% from the comparable as-filed period.
Operating cash-flow margin changed -139 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +92 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.